Patent details
EP1864981 Title: Thrombopoietin mimetics.
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
- Publication number:
- EP1864981
- WO Application Number:
- Type:
- European Patent Granted for NL
- Status:
- Lapsed by non-payment of annual fee Art. 62 ROW
- Publication Title:
- Title When Made Available For Viewing:
- Reason Lapsed:
- Application number:
- EP07112105.7
- WO Publication Number:
- EPO Publication Language:
- English
- SPC Number:
- First Applicant Residence Country:
- United States of America (US)
- Publications:
Dates
- Filing date:
- 24/05/2001
- Grant date:
- 22/07/2009
- EP Publication Date:
- 22/07/2009
- WO Publication Date:
- Claims Translations Received Date:
- Claims Translation B1 Received Date:
- Claims Translation B2 Received Date:
- Claims Translation B3 Received Date:
- Lapsed By Non Payment Annual Fee Date:
- 01/06/2017
- Renunciation Date:
- NullificationDate:
- Published:
- Due To Cession Date:
- Registration date:
- 22/07/2009
- EP B1 Publication Date:
- 22/07/2009
- EP B2 Publication Date:
- EP B3 Publication Date:
- Description Translation B1 Received Date:
- Description Translation B2 Received Date:
- Description Translation B3 Received Date:
- Expiration date:
- 23/05/2021
- Lapsed By Expiration Date:
- Revocation Date:
- Invalidity Date:
- Response To Novelty Search Report Received:
- Patent Granting Request:
- Lapsed date:
Applicant/holder
- From:
- 01/07/2016
- Name:
- Novartis AG
- Address:
- Lichtstrasse 35, 4056, Basel, Switzerland (CH)
Historical Applicant/holder
- From:
- 01/07/2016
- To:
- 01/07/2016
- Name:
- GlaxoSmithKline LLC
- Address:
- 2711 Centerville Road, Suite 400, 19808, Wilmington, Delaware, United States of America (US)
- From:
- 01/07/2016
- To:
- 01/07/2016
- Name:
- Glaxo Group Limited
- Address:
- 980 Great West Road, TW8 9GS, Brentford, Middlesex, United Kingdom (GB)
- From:
- 01/07/2016
- To:
- 01/07/2016
- Name:
- Novartis Pharma AG
- Address:
- Lichtstrasse 35, 4056, Basel, Switzerland (CH)
- From:
- 22/07/2009
- To:
- 01/07/2016
- Name:
- Smithkline Beecham Corporation
- Address:
- One Franklin Plaza, P.O. Box 7929, 19101, PHILADELPHIA, PENNSYLVANIA, United States of America (US)
Domicile Holder
- Name:
- ir. F.A. Geurts c.s.
- From:
- 22/07/2009
- Address:
- Octrooibureau Vriesendorp & Gaade B.V. Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
- To:
Inventor
1
- Name:
- Kevin, J. Duffy
- Address:
- PA 19426, Collegeville, United States of America (US)
2
- Name:
- Daniel, F. Eppley
- Address:
- TX 79605, Abilene, United States of America (US)
3
- Name:
- Connie, L. Erickson-Miller
- Address:
- PA 19426, Collegeville, United States of America (US)
4
- Name:
- Julian Jenkins
- Address:
- UB6 0HE, Greenford, Middlesex, United Kingdom (GB)
5
- Name:
- Nannan Liu
- Address:
- PA 19426, Collegeville, United States of America (US)
6
- Name:
- Juan, I. Luengo
- Address:
- PA 19426, Collegeville, United States of America (US)
7
- Name:
- Alan, T. Price
- Address:
- PA 19426, Collegeville, United States of America (US)
8
- Name:
- Antony, N. Shaw
- Address:
- PA 19426, Collegeville, United States of America (US)
9
- Name:
- Sophie Visonneau
- Address:
- PA 19426, Collegeville, United States of America (US)
10
- Name:
- Kenneth Wiggall
- Address:
- PA 19426, Collegeville, United States of America (US)
Priority
1
- Priority Patent Number:
- 228929 P
- Priority Date:
- 30/08/2000
- Priority Country:
- United States of America (US)
2
- Priority Patent Number:
- 207084 P
- Priority Date:
- 25/05/2000
- Priority Country:
- United States of America (US)
Classification
- Main IPC Class:
- C07D 403/12;
- IPC or IDT classification:
- A61K 31/41; A61P 7/00;
Publication
Bulletin
1
- Bulletin Heading:
- VRV
- Journal edition number:
- 02/18
- Publication date:
- 03/01/2018
- Description:
- Lapse or annulment
2
- Bulletin Heading:
- CO
- Journal edition number:
- 39/16
- Publication date:
- 28/09/2016
- Description:
- Changes in the Netherlands Patent Register
3
- Bulletin Heading:
- CO
- Journal edition number:
- 39/16
- Publication date:
- 28/09/2016
- Description:
- Changes in the Netherlands Patent Register
4
- Bulletin Heading:
- CO
- Journal edition number:
- 39/16
- Publication date:
- 28/09/2016
- Description:
- Changes in the Netherlands Patent Register
5
- Bulletin Heading:
- CO
- Journal edition number:
- 39/16
- Publication date:
- 28/09/2016
- Description:
- Changes in the Netherlands Patent Register
6
- Bulletin Heading:
- MED
- Journal edition number:
- 2010/11
- Publication date:
- 28/04/2010
- Description:
- Other communications
7
- Bulletin Heading:
- EP4
- Journal edition number:
- 2009/12
- Publication date:
- 01/12/2009
- Description:
- European patents granted in amended form for the Netherlands
8
- Bulletin Heading:
- EP2
- Journal edition number:
- 2009/10
- Publication date:
- 01/10/2009
- Description:
- European patents granted for the Netherlands
European Patent Bulletin
- Issue number:
- 200930
- Publication date:
- 22/07/2009
- Description:
- Grant (B1)
Deed
Change of owner(s)
- Change Kind/ Decision Type:
- Change of Legal Entity
- Deed Number:
- RC201601899A
- Date Registered:
- 01/07/2016
- License Effective Date:
- License Expiration Date:
- Scope of License:
- Deed Filer:
- ir. F.A. Geurts c.s.
- Journal Edition Number:
- Text:
- Deed Status:
- Country Code:
- Updated License Number:
- Terminated License Number:
Added Owner(s)
- Name:
- GlaxoSmithKline LLC
- Address:
- 2711 Centerville Road, Suite 400, 19808, Wilmington, Delaware, United States of America (US)
Changed Pledgee
- Name:
- Address:
Removed Usufructuary
- Name:
- Address:
Added Usufructuary
- Name:
- Address:
Changed Usufructuary
- Name:
- Address:
Change of owner(s)
- Change Kind/ Decision Type:
- Assignment
- Deed Number:
- RC201601899B
- Date Registered:
- 01/07/2016
- License Effective Date:
- License Expiration Date:
- Scope of License:
- Deed Filer:
- ir. F.A. Geurts c.s.
- Journal Edition Number:
- Text:
- Deed Status:
- Country Code:
- Updated License Number:
- Terminated License Number:
Added Owner(s)
- Name:
- Glaxo Group Limited
- Address:
- 980 Great West Road, TW8 9GS, Brentford, Middlesex, United Kingdom (GB)
Changed Pledgee
- Name:
- Address:
Removed Usufructuary
- Name:
- Address:
Added Usufructuary
- Name:
- Address:
Changed Usufructuary
- Name:
- Address:
Change of owner(s)
- Change Kind/ Decision Type:
- Assignment
- Deed Number:
- RC201601899C
- Date Registered:
- 01/07/2016
- License Effective Date:
- License Expiration Date:
- Scope of License:
- Deed Filer:
- ir. F.A. Geurts c.s.
- Journal Edition Number:
- Text:
- Deed Status:
- Country Code:
- Updated License Number:
- Terminated License Number:
Added Owner(s)
- Name:
- Novartis Pharma AG
- Address:
- Lichtstrasse 35, 4056, Basel, Switzerland (CH)
Changed Pledgee
- Name:
- Address:
Removed Usufructuary
- Name:
- Address:
Added Usufructuary
- Name:
- Address:
Changed Usufructuary
- Name:
- Address:
Change of owner(s)
- Change Kind/ Decision Type:
- Assignment
- Deed Number:
- RC201601899G
- Date Registered:
- 01/07/2016
- License Effective Date:
- License Expiration Date:
- Scope of License:
- Deed Filer:
- ir. F.A. Geurts c.s.
- Journal Edition Number:
- Text:
- Deed Status:
- Country Code:
- Updated License Number:
- Terminated License Number:
Added Owner(s)
- Name:
- Novartis AG
- Address:
- Forum 1, Novartis Campus, 4056, Basel, Switzerland (CH)
Changed Pledgee
- Name:
- Address:
Removed Usufructuary
- Name:
- Address:
Added Usufructuary
- Name:
- Address:
Changed Usufructuary
- Name:
- Address:
Annual Fee
- Annual Fee(s) Due Date:
- Annual Fee Number:
- Last Annual Payment Date:
- 10/05/2016
- Last Annual Fee Paid Number:
- 16
- Last Annual Fee Paid Amount:
- 1000 Euro
- Payer:
- Computer Patent Annuities Limited (CPA)
| Filing date | Document type | Document Description | Number of pages | File Type | ||
|---|---|---|---|---|---|---|
| 28/09/2016 | Outgoing Correspondence | Letter registration deed | 2 | /5/0/1/2/1/0507112105/docs/ep07112105.7_5_86692l118.pdf | ||
| 01/07/2016 | Incoming Correspondence Paper | Accompanying letter incoming document | 2 | /5/0/1/2/1/0507112105/docs/ep07112105.7_1_incomingcorrespondencepaper20160831092630978.pdf | ||
| 01/07/2016 | Request for Change | First filed deed | 3 | /5/0/1/2/1/0507112105/docs/ep07112105.7_3_rfc20160927015124796.pdf | ||
| 01/07/2016 | Request for Change | First filed deed | 12 | /5/0/1/2/1/0507112105/docs/ep07112105.7_7_rfc20160831092631080.pdf | ||
| 09/10/2009 | Incoming Correspondence Paper | Other | 2 | /5/0/1/2/1/0507112105/docs/ep07112105.7_0_incomingcorrespondencepaper20091009.pdf | ||
| 23/09/2009 | Incoming Correspondence Paper | Correspondence address details | 1 | /5/0/1/2/1/0507112105/docs/ep07112105.7_4_incomingcorrespondencepaper20090923.pdf | ||
| 23/09/2009 | Claims | Translated claims | 3 | /5/0/1/2/1/0507112105/docs/ep07112105.7_6_claims20090923.pdf | ||
| 03/08/2009 | Incoming Correspondence Paper | Other | 1 | /5/0/1/2/1/0507112105/docs/ep07112105.7_2_incomingcorrespondencepaper20090803.pdf |